Early administration of remdesivir plus convalescent plasma therapy is effective to treat COVID-19 pneumonia in B-cell depleted patients with hematological malignancies

Patients with hematological malignancies (HMs) are at a higher risk of developing severe form and protracted course of COVID-19 disease. We investigated whether the combination of viral replication inhibition with remdesivir and administration of anti-SARS-CoV-2 immunoglobulins with convalescent pla...

Descripción completa

Detalles Bibliográficos
Autores principales: Magyari, Ferenc, Pinczés, László Imre, Páyer, Edit, Farkas, Katalin, Ujfalusi, Szilvia, Diószegi, Ágnes, Sik, Máté, Simon, Zsófia, Nagy, Gergely, Hevessy, Zsuzsanna, Nagy, Béla, Illés, Árpád
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9282831/
https://www.ncbi.nlm.nih.gov/pubmed/35836007
http://dx.doi.org/10.1007/s00277-022-04924-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9282831/
https://www.ncbi.nlm.nih.gov/pubmed/35836007
http://dx.doi.org/10.1007/s00277-022-04924-6

Ejemplares similares